IMP
Process View
osteoblast development
The process whose specific outcome is the progression of an osteoblast over time, from its formation to the mature structure. Osteoblast development does not include the steps involved in committing a cranial neural crest cell or an osteoprogenitor cell to an osteoblast fate. An osteoblast is a cell that gives rise to bone.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "osteoblast development"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SMAD9 | SMAD family member 9 | 0.147 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.130 | ||
| ATF3 | activating transcription factor 3 | 0.118 | ||
| JUN | jun proto-oncogene | 0.103 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.084 | ||
| HIPK3 | homeodomain interacting protein kinase 3 | 0.051 | ||
| HDAC7 | histone deacetylase 7 | 0.040 | ||
| SKIL | SKI-like oncogene | 0.038 | ||
| GABARAP | GABA(A) receptor-associated protein | 0.037 | ||
| MEF2C | myocyte enhancer factor 2C | 0.032 | ||
| HDAC3 | histone deacetylase 3 | 0.032 | ||
| MEF2A | myocyte enhancer factor 2A | 0.028 | ||
| TP63 | tumor protein p63 | 0.021 | ||
| MSX1 | msh homeobox 1 | 0.020 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.019 | ||
| JUNB | jun B proto-oncogene | 0.019 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.018 | ||
| HEYL | hairy/enhancer-of-split related with YRPW motif-like | 0.016 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.016 | ||
| CAPRIN2 | caprin family member 2 | 0.015 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.014 | ||
| LATS1 | LATS, large tumor suppressor, homolog 1 (Drosophila) | 0.013 | ||
| CXXC5 | CXXC finger protein 5 | 0.013 | ||
| MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.013 | ||
| TRAF4 | TNF receptor-associated factor 4 | 0.013 | ||
| FHL2 | four and a half LIM domains 2 | 0.012 | ||
| IER2 | immediate early response 2 | 0.012 | ||
| HDAC5 | histone deacetylase 5 | 0.011 | Mouse | |
| AR | androgen receptor | 0.011 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.011 | ||
| FANCE | Fanconi anemia, complementation group E | 0.011 | ||
| MYST3 | MYST histone acetyltransferase (monocytic leukemia) 3 | 0.011 | ||
| MYH9 | myosin, heavy chain 9, non-muscle | 0.011 | ||
| MIF4GD | MIF4G domain containing | 0.011 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.010 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.010 | ||
| SIRT6 | sirtuin 6 | 0.010 | ||
| MECP2 | methyl CpG binding protein 2 (Rett syndrome) | 0.010 | ||
| PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.010 |